PF299804

Min.Order / FOB Price:Get Latest Price

0 Metric Ton	Negotiable

0 Metric Ton

Negotiable

high quality Dacomitinib 1110813-31-4 API-Dacomitinib, High quality 1110813-31-4 Dacomitinib PF299804Dacomitinib,1110813-31-4 99.5%

Arromax mission: promoting human health, using our creativity to realize self-values and undertake social responsibility

Arromax vision: to be a leading global platform for technological innovation and a famous brand of new drugs

Arromax culture: be united, struggling, truth-seeking and creative

Arromax R&D Capabilities:

(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide Basic information

Product Name:	(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide
Synonyms:	(E)-N-(4-((3-chloro-4-fluorophenyl)aMino)-7-Methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enaMide;PF299804;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide;Dacomitinib;PF-00299804-03;PF-00299804;DacoMitinib (PF-00299804);DacoMitinib,PF299804
CAS:	1110813-31-4
MF:	C24H25ClFN5O2
MW:	469.9390032
EINECS:	-0
Product Categories:	Anti-cancer&immunity
Mol File:	1110813-31-4.mol